Skip to main content
Top
Published in: Pediatric Cardiology 7/2017

01-10-2017 | Letter To The Editor

Future Applications of the Selective Prostacyclin (IP) Receptor Agonist Selexipag in Pediatric Pulmonary Hypertension

Authors: Martin Koestenberger, Georg Hansmann

Published in: Pediatric Cardiology | Issue 7/2017

Login to get access

Excerpt

To the Editor, …
Literature
2.
go back to reference Hansmann G, Apitz C (2016) Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Heart 102(Suppl 2):ii67–85CrossRefPubMed Hansmann G, Apitz C (2016) Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Heart 102(Suppl 2):ii67–85CrossRefPubMed
3.
go back to reference Ewert R, Richter MJ, Steringer-Mascherbauer R, Grünig E, Lange TJ, Opitz CF et al (2017) Intravenous treprostinil infusion via a fully implantable pump for pulmonary arterial hypertension. Clin Res Cardiol. doi:10.1007/s00392-017-1114-1 Ewert R, Richter MJ, Steringer-Mascherbauer R, Grünig E, Lange TJ, Opitz CF et al (2017) Intravenous treprostinil infusion via a fully implantable pump for pulmonary arterial hypertension. Clin Res Cardiol. doi:10.​1007/​s00392-017-1114-1
4.
go back to reference Geerdink LM, Bertram H, Hansmann G (2017) First-in-child use of the oral selective prostacyclin IP receptor agonist selexipag in pulmonary arterial hypertension. Pulm Circ 7:551–554CrossRefPubMedPubMedCentral Geerdink LM, Bertram H, Hansmann G (2017) First-in-child use of the oral selective prostacyclin IP receptor agonist selexipag in pulmonary arterial hypertension. Pulm Circ 7:551–554CrossRefPubMedPubMedCentral
5.
go back to reference Hansmann G, Apitz C (2016) The need for comprehensive cardiac catheterization in children with pulmonary hypertension. J Am Coll Cardiol 67:1009–1010CrossRefPubMed Hansmann G, Apitz C (2016) The need for comprehensive cardiac catheterization in children with pulmonary hypertension. J Am Coll Cardiol 67:1009–1010CrossRefPubMed
6.
go back to reference Hansmann G (2017) Pulmonary hypertension in infants, children, and young adults. J Am Coll Cardiol 69:2551–2569CrossRefPubMed Hansmann G (2017) Pulmonary hypertension in infants, children, and young adults. J Am Coll Cardiol 69:2551–2569CrossRefPubMed
7.
go back to reference Koestenberger M, Apitz C, Abdul-Khaliq H, Hansmann G (2016) Transthoracic echocardiography for the evaluation of children and adolescents with suspected or confirmed pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Heart 102(Suppl 2):ii14–22CrossRefPubMed Koestenberger M, Apitz C, Abdul-Khaliq H, Hansmann G (2016) Transthoracic echocardiography for the evaluation of children and adolescents with suspected or confirmed pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Heart 102(Suppl 2):ii14–22CrossRefPubMed
Metadata
Title
Future Applications of the Selective Prostacyclin (IP) Receptor Agonist Selexipag in Pediatric Pulmonary Hypertension
Authors
Martin Koestenberger
Georg Hansmann
Publication date
01-10-2017
Publisher
Springer US
Published in
Pediatric Cardiology / Issue 7/2017
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-017-1699-1

Other articles of this Issue 7/2017

Pediatric Cardiology 7/2017 Go to the issue